Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome.
Study Goal
The researchers aimed to compare the effects of a rapeseed oil-enriched diet (high in MUFA and ALA) versus an olive oil diet (high in MUFA but low in ALA) on weight loss and cardiovascular risk factors in patients with metabolic syndrome.
Results Summary
Both diets led to significant weight loss and improvements in cardiovascular risk factors, but the rapeseed oil diet showed greater reductions in diastolic blood pressure and serum triglycerides compared to the olive oil diet. No significant inter-group differences were observed for other measured outcomes.
Population
Eighty-one patients with metabolic syndrome.
Effective Dosage
ALA intake of 3.5 g/day via rapeseed oil.
Duration
6 months.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
hypoenergetic diet with low energy density enriched in rapeseed oil, resulting in high MUFA content and an ALA intake of 3.5 g/d | decrease | body weight | eighty-one patients with the metabolic syndrome | -7.8 kg | significantly reduced | #1 |
olive oil diet rich in MUFA, but with a low ALA content | decrease | body weight | eighty-one patients with the metabolic syndrome | -6.0 kg | significantly reduced | #2 |
hypoenergetic diet with low energy density enriched in rapeseed oil, resulting in high MUFA content and an ALA intake of 3.5 g/d | decrease | systolic blood pressure | eighty-one patients with the metabolic syndrome | - | significant decreases | #3 |
hypoenergetic diet with low energy density enriched in rapeseed oil, resulting in high MUFA content and an ALA intake of 3.5 g/d | decrease | total cholesterol | eighty-one patients with the metabolic syndrome | - | significant decreases | #4 |
hypoenergetic diet with low energy density enriched in rapeseed oil, resulting in high MUFA content and an ALA intake of 3.5 g/d | decrease | LDL-cholesterol | eighty-one patients with the metabolic syndrome | - | significant decreases | #5 |
hypoenergetic diet with low energy density enriched in rapeseed oil, resulting in high MUFA content and an ALA intake of 3.5 g/d | decrease | insulin levels | eighty-one patients with the metabolic syndrome | - | significant decreases | #6 |
olive oil diet rich in MUFA, but with a low ALA content | decrease | systolic blood pressure | eighty-one patients with the metabolic syndrome | - | significant decreases | #7 |
olive oil diet rich in MUFA, but with a low ALA content | decrease | total cholesterol | eighty-one patients with the metabolic syndrome | - | significant decreases | #8 |
olive oil diet rich in MUFA, but with a low ALA content | decrease | LDL-cholesterol | eighty-one patients with the metabolic syndrome | - | significant decreases | #9 |
olive oil diet rich in MUFA, but with a low ALA content | decrease | insulin levels | eighty-one patients with the metabolic syndrome | - | significant decreases | #10 |
rapeseed oil diet | decrease | diastolic blood pressure | eighty-one patients with the metabolic syndrome | - | declined more | #11 |
high ALA intake | decrease | concentrations of serum TAG | eighty-one patients with the metabolic syndrome | - | significantly reduced | #12 |
low ALA group | no change | concentrations of serum TAG | eighty-one patients with the metabolic syndrome | - | not reduced | #13 |
In therapy of the metabolic syndrome, the optimal dietary approach with regard to its macronutrient composition and metabolically favourable food components, such as the plant-derived n-3 fatty acid α-linolenic acid (ALA), is still a matter of debate. We investigated the effects of a hypoenergetic diet with low energy density (ED) enriched in rapeseed oil, resulting in high MUFA content and an ALA intake of 3.5 g/d on body weight and cardiovascular risk profile in eighty-one patients with the metabolic syndrome in comparison with an olive oil diet rich in MUFA, but with a low ALA content. After a 6-month dietary intervention, body weight was significantly reduced in the rapeseed oil and olive oil groups ( -7.8 v. -6.0 kg; P < 0.05). There were significant decreases in systolic blood pressure, total cholesterol and LDL-cholesterol, and insulin levels in both groups (P < 0.05). For all of these changes, no inter-group differences were observed. After the rapeseed oil diet, diastolic blood pressure declined more than after the olive oil diet (P < 0.05 for time × group interaction). Furthermore, concentrations of serum TAG were significantly reduced after the high ALA intake, but not in the low ALA group (P < 0.05 for time × group interaction). In conclusion, our dietary food pattern with a low ED and high intakes of MUFA and ALA may be a practical approach for long-term dietary treatment in patients with the metabolic syndrome, leading to weight reduction and an improvement in the overall cardiovascular risk profile.